This online event will explore the challenges when working with Orphan Drugs and Rare Diseases, and the benefits from a development viewpoint. It will explore the benefits of early planning and engagement with regulatory authorities, as well as looking into case studies on what has and has not been an effective strategy in Rare Disease trials.
07-07 December 2022